AUTL Chart
See on advanced chart >
About
Autolus Therapeutics plc was incorporated in England and Wales on February 2, 2018. The company is a biopharmaceutical company developing next-generation programmed T cell therapies for the treatment of cancer. Using broad suite of proprietary and modular T...
Read More
- HighlightA clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies
- ExchangeNASDAQ
- Listing Date06/22/2018
- Established Date02/02/2018
- Full-time Employees463
- AddressThe MediaWorks 191 Wood Lane London W12 7FP United Kingdom
- Tel44-20-38296230
- Website
- Fiscal Year End Date12/31
- Security TypeAmerican Depositary Receipt (Common Stock)
Industry
Biotechnology